Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Annales De Biologie Clinique|August 15, 2014
[Triazole antifungal agents: practice guidelines of therapeutic drug monitoring and perspectives in treatment optimization]Simon Scodavolpe, Sylvie Quaranta, Bruno Lacarelle, et al.
Expert Review of Clinical Pharmacology|May 17, 2018
Seek and destroy: improving PK/PD profiles of anticancer agents with nanoparticlesAnne Rodallec, Raphaelle Fanciullino, Bruno Lacarelle, et al.
Annales De Biologie Clinique|October 23, 2014
[Clinical application, limits and perspectives of pharmacogenetic and pharmacokinetic analysis of anticancer drugs]Anne-Sophie Chantry, Sylvie Quaranta, Joseph Ciccolini, et al.
Critical Reviews in Oncology/Hematology|August 12, 2018
Pharmacokinetics variability: Why nanoparticles are not just magic-bullets in oncologyAnne Rodallec, Sebastien Benzekry, Bruno Lacarelle, et al.
Clinical Colorectal Cancer|October 6, 2010
Routine dihydropyrimidine dehydrogenase testing for anticipating 5-fluorouracil-related severe toxicities: hype or hope?Joseph Ciccolini, Eva Gross, Laetitia Dahan, et al.
Nature Reviews. Clinical Oncology|November 25, 2015
Computational oncology--mathematical modelling of drug regimens for precision medicineDominique Barbolosi, Joseph Ciccolini, Bruno Lacarelle, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2002
Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patientsCaroline Solas, Alain Lafeuillade, Philippe Halfon, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|November 3, 2016
Comparison of Cannabinoid Concentrations in Plasma, Oral Fluid and Urine in Occasional Cannabis Smokers After Smoking Cannabis CigaretteAmélie Marsot, Christine Audebert, Laurence Attolini, et al.
HIV Clinical Trials|January 31, 2002
Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlationsAlain Lafeuillade, Caroline Solas, Philippe Halfon, et al.
Pageof 9